abstract |
The invention relates to a pharmaceutical composition, in particular a dermatological composition, comprising laropiprant, an ester or a pharmaceutically acceptable salt thereof and oxymetazoline or a pharmaceutically acceptable salt thereof, and to the use of same for the treatment of dermatological conditions, in particular rosacea. |